Skip to main content
. Author manuscript; available in PMC: 2019 Jan 4.
Published in final edited form as: Immunohorizons. 2018 Nov;2(10):314–323. doi: 10.4049/immunohorizons.1800049

FIGURE 5. The effects of neuropeptide treatment on MHC II within magnetic bead–containing vesicles.

FIGURE 5.

The isolated magnetic bead–containing vesicles were immunoblotted for Rab5 and MHC II. The ratio of MHC II to Rab5 was calculated from the intensity of the bands. Presented are (A) representative immunoblot and (B) the mean ± SEM of the relative ratio of MHC II/Rab5 from three independent experiments. There was no significant suppression in the expression of MHC II to Rab5 in the macrophages cotreated with α-MSH and NPY. This demonstrates that MHC II is still associated with phagosomes.